基于mRNA的癌症疫苗的进展
1Institute for Immunology and School of Medicine, Tsinghua University, Medical Research Building, No. 30 Haidian Shuangqing Road, Beijing 100084, China.
Vaccines
|October 28, 2023
概括
使者RNA (mRNA) 癌症疫苗正在获得吸引力,利用最近的技术进步. 本综述强调了mRNA癌症疫苗开发,临床试验和未来免疫疗法应用方面的进展.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 生物技术是生物技术.
背景情况:
- 癌症仍然是全球主要的死亡原因,需要创新的治疗策略.
- 癌症疫苗,一种免疫治疗形式,在临床前表现有希望,但在临床中面临着翻译挑战.
- 在COVID-19大流行中mRNA技术的成功使得人们对基于mRNA的癌症疫苗产生了新的兴趣.
研究的目的:
- 在过去五年中,审查基于mRNA的癌症疫苗的最新进展.
- 总结关键方面,包括作用机制,新抗原发现,辅助剂和输送系统.
- 提供当前临床试验的概述和mRNA癌症疫苗在免疫治疗中的未来方向.
主要方法:
- 文献综述,重点关注过去五年的科学出版物和临床试验数据.
- 综合有关mRNA疫苗技术,癌症免疫学和治疗开发的信息.
- 分析新抗原识别,辅助剂配方和基于纳米粒子的输送系统的进展情况.
主要成果:
- 在mRNA癌症疫苗技术方面取得了重大进展,主要是由于传递系统和辅助剂开发的进步.
- 目前的临床试验正在评估不同类型癌症中各种mRNA癌症候选疫苗的安全性和有效性.
- 该审查巩固了目前对mRNA疫苗机制及其在个性化癌症治疗中的潜力的理解.
结论:
- mRNA癌症疫苗代表了癌症免疫治疗的前沿,基于最近的技术突破.
- 对新抗原发现,优化输送和组合疗法的持续研究将对临床成功至关重要.
- 本综述为推进基于mRNA的癌症治疗策略的研究人员提供了宝贵的见解.
相关概念视频
Cancer Vaccines
383
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
383
Microorganisms in Medicine and Therapeutics
35
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
35
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Tumor Immunotherapy
538
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
538
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K


